Savara Inc
SVRA · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Parker Braden C.: Form 4
Insider disclosure · Filed · Report period 24 Sep 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- SVRA · 805111101 - Common Stock, par value $0.001 per share (the "Shares")
Company details and SEC sources
CIK 0001160308 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SVRA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 6836 Bee Cave Road, Building 3, Suite 201, Austin, TX, 78746
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Mast Therapeutics, Inc. (to 25 Apr 2017), ADVENTRX PHARMACEUTICALS INC (to 01 Mar 2013), BIOKEYS PHARMACEUTICALS INC (to 15 May 2003)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields